30592 Federal Register / Vol. 74, No. 122 / Friday, June 26, 2009 / Notices 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel; Molecular and Oncology 

Support Services. 

Date: July 16, 2009. 

Time: 10 a.m. to 12:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: NIEHS/National Institues of Health, 

Keystone Building, 530 Davis Drive, Research 

Triangle Park, NC 207709, (Telephone 

Conference Call). 

Contact Person: RoseAnne M. McGee, 

Associate Scientific Review Administrator, 

Scientific Review Branch, Division of 

Extramural Research and Training, Nat. 

Institute of Environmental Health Sciences, 

P.O. Box 12233, MD EC–30, Research 

Triangle Park, NC 27709, (919) 541–0752, 

mcgee1@niehs.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: June 19, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–15068 Filed 6–25–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. NCI ARRA 

Grand Opportunities Cancer Vaccines. 

Date: August 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel & 

Conf. Ctr., Bethesda, MD. 

Contact Person: Shamala K. Srinivas, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 8123, Bethesda, 

MD 20892. 301–594–1224. ss537t@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. NCI–ARRA 

Grand Opportunities—Stem Cells. 

Date: August 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel and 

Conf. Ctr., Bethesda, MD. 

Contact Person: Shakeel Ahmad, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8139, 

Bethesda, MD 20892–8328. (301) 594–0114. 

ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. NCI ARRA 

Grand Opportunities—Transcriptional & 

Translational. 

Date: August 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel and 

Conf. Ctr., Bethesda, MD. 

Contact Person: Thomas M Vollberg, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 7142, Bethesda, 

MD 20892. 301–594–9582. 

vollbert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. NCI ARRA 

Grand Opportunities-Molecular Targets & 

Cancer Genomics. 

Date: August 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel and 

Conf. Ctr., Bethesda, MD. 

Contact Person: Adriana Stoica, PhD, 

Scientific Review Officer, Special Review & 

Logistics Branch, Division of Extramural 

Activities, National Cancer Insitute, NIH, 

6116 Executive Blvd, Ste 703, Rm 7072, 

Bethesda, MD 20892–8329. 301–594–1408. 

Stoicaa2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control; 93.701, ARRA Related 

Biomedical Research and Research Support 

Awards, National Institutes of Health, HHS) 

Dated: June 19, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–15067 Filed 6–25–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. NCI–ARRA 

Grand Opportunities—Nanotechnology. 

Date: July 22–23, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel and 

Conference Ctr., Bethesda, MD. 

Contact Person: Peter J. Wirth, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 8131, Bethesda, 

MD 20892–8328. 301–496–7565. 

pw2q@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. NCI–ARRA 

Grand Opportunities—Comparative 

Oncology. 

Date: August 4–5, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel and 

Conf. Ctr., Bethesda, MD. 

Contact Person: Caron A. Lyman, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Blvd., Room 8119, Bethesda, MD 

20892–8328. 301–451–4761. 

lymanc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. NCI–ARRA 

Grand Opportunities—Clinical/Translational. 

Federal Register / Vol. 74, No. 122 / Friday, June 26, 2009 / Notices 30593 

Date: August 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel & 

Conference Center, Bethesda, MD. 

Contact Person: Timothy C. Meeker, MD, 

PhD, Scientific Review Officer, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8103, Bethesda, MD 20892. (301) 594–1279. 

meekert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. NCI–ARRA 

Grand Opportunity. 

Date: August 5–6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel & 

Conf. Ctr., Bethesda, MD. 

Contact Person: Jeannette F. Korczak, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Room 

8115, Bethesda, MD 20892. 301–496–9767. 

korczakj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control; 93.701, ARRA Related 

Biomedical Research and Research Support 

Awards, National Institutes of Health, HHS) 

Dated: June 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–15066 Filed 6–25–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI Grant Opportunities in Comparative 

Effectiveness (ARRA). 

Date: July 8, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Robert Blaine Moore, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7213, 

Bethesda, MD 20892, 301–594–8394, 

mooreb@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research; 93.701, ARRA 

Related Biomedical Research and Research 

Support Awards, National Institutes of 

Health, HHS) 

Dated: June 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–15065 Filed 6–25–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; R13 

Conference Grant Review. 

Date: July 1, 2009. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 8041, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Bratin K. Saha, PhD, 

Scientific Review Officer, Program 

Coordination and Referral Branch, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8041, Bethesda, MD 20892, (301) 402– 

0371, sahab@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to scheduling 

conflicts. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Small 

Grants for Behavioral Research in Cancer 

Control. 

Date: July 7, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Legacy Hotel and Meeting 

Center, 1775 Rockville Pike, Rockville, MD 

20852. 

Contact Person: Gerald G. Lovinger, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8101, 

Bethesda, MD 20892–8329, 301/496–7987, 

lovingeg@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to scheduling 

conflicts. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Quantitative Imaging. 

Date: July 22–23, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Rockville, MD 20852. 

Contact Person: Sherwood Githens, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Blvd., Room 8053, Bethesda, MD 

20892, 301/435–1822, githenss@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: June 18, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–15064 Filed 6–25–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as